MS resource utilization by year, n (proportion of patients, %).

Figshare2019-05-14 更新2026-04-29 收录

多发性硬化症医疗

数据链接：

https://figshare.com/articles/dataset/MS_resource_utilization_by_year_n_proportion_of_patients_/8125856 数据链接链接失效反馈

官方服务：

资源简介：

MS resource utilization by year, n (proportion of patients, %).

创建时间：

2019-05-14

When does economic model type become a decisive factor in health technology appraisals? Learning from the expanding treatment options for relapsing–remitting multiple sclerosis

健康技术评估

多发性硬化症医疗

Objectives: Specific economic model types often become de facto standard for health technology appraisal over time. Markov and discrete event simulation (DES) models were compared to investigate the i

NIAID Data Ecosystem70

Candidate Gene Study of TRAIL and TRAIL Receptors : Association with Response to Interferon Beta Therapy in Multiple Sclerosis Patients

治疗反应预测

多发性硬化症医疗

TRAIL and TRAIL Receptor genes have been implicated in Multiple Sclerosis pathology as well as in the response to IFN beta therapy. The objective of our study was to evaluate the association of these

NIAID Data Ecosystem40

Supplementary materials: Cost–effectiveness analysis of prolonged-release fampridine to treat walking disability of multiple sclerosis in China

多发性硬化症医疗

成本效益分析

These are peer-reviewed supplementary materials for the article 'Cost–effectiveness analysis of prolonged-release fampridine to treat walking disability of multiple sclerosis in China' published in th

Figshare2024-05-03 更新30

Annual per patient costs to manage MS patients (DMDs excluded).

多发性硬化症医疗

医疗费用分析

Elaborated from Ponzio et al. [2]. Costs were inflated to Euro 2014 [18].

NIAID Data Ecosystem40

RebiQoL: A randomized trial of telemedicine patient support program for health-related quality of life and adherence in people with MS treated with Rebif

多发性硬化症医疗

患者报告结局与依从性

RebiQoL was a phase IV multicenter randomized study to assess the impact of a telemedicine patient support program (MSP) on health-related quality of life (HRQoL) in patients with relapsing-remitting

NIAID Data Ecosystem40

MS resource utilization by year, n (proportion of patients, %).

资源简介：

相关数据集